AI ScreeningAI ChatPricing
  1. JP-listed companies
  2. Soiken Holdings Inc.
  3. Financials
  4. Total cash & short-term investments

Soiken Holdings Inc.【JP:2385】

Market cap
¥6.3B
P/E ratio
210.4x
Soken Medical Holdings develops biomarker testing systems for food and pharmaceutical companies while selling health products directly to consumers.
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndTotal cash & short-term investments (Million JPY)YoY (%)
Jun 30, 20255,258+9.78%
Jun 30, 20244,790-19.44%
Jun 30, 20235,946-4.37%
Jun 30, 20226,217+46.09%
Jun 30, 20214,256-5.71%
Jun 30, 20204,513+36.72%
Jun 30, 20193,301+11.06%
Jun 30, 20182,972-10.97%
Jun 30, 20173,339-0.89%
Jun 30, 20163,369+9.18%
Jun 30, 20153,085+14.02%
Jun 30, 20142,706

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)